AMIX

Autonomix Medical, Inc.

Healthcare · $2M market cap

Verdict

We can't put a fair value on AMIX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-82.2% a year✗
Sales growth—?
Free cash flow growth—?
Return on invested capital—?

Follow AMIX

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 3, 2026: no open-market purchases and 3 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

About Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works